Abstract |
In 59 patients with ductal pancreatic cancer the monoclonal antibody (MAb) BW 494, which detects the CA 494 glycoprotein antigen, was analyzed in comparison with the reference tumor markers CA 19-9 and CEA. Eighty-one patients with non-pancreatic malignancies of the gastrointestinal (GI) tract, 95 with chronic pancreatitis, 124 with benign non-pancreatic GI diseases, 30 with diabetes mellitus (type I or type II) and 114 healthy blood donors served as controls. The sensitivity of pancreatic cancer was 90%, 44% and 90% for CA 19-9, CEA and CA 494, respectively. In chronic pancreatitis, as the most important control population for pancreatic cancer, the specificity was 85%, 72% and 94% for CA 19-9, CEA and CA 494, respectively.
|
Authors | H Friess, M Büchler, B Auerbach, A Weber, P Malfertheiner, K Hammer, N Madry, S Greiner, K Bosslet, H G Beger |
Journal | International journal of cancer
(Int J Cancer)
Vol. 53
Issue 5
Pg. 759-63
(Mar 12 1993)
ISSN: 0020-7136 [Print] United States |
PMID | 8449599
(Publication Type: Journal Article)
|
Chemical References |
- Antigens, Tumor-Associated, Carbohydrate
- Biomarkers, Tumor
- Carcinoembryonic Antigen
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antigens, Tumor-Associated, Carbohydrate
(blood)
- Biomarkers, Tumor
(blood)
- Carcinoembryonic Antigen
(blood)
- Diabetes Mellitus
(blood)
- Female
- Humans
- Male
- Middle Aged
- Pancreatic Diseases
(blood)
- Pancreatic Neoplasms
(blood)
- Sensitivity and Specificity
|